{{Rsnum
|rsid=1721082
|Gene=FGF20
|Chromosome=8
|position=16992623
|Orientation=minus
|GMAF=0.3737
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=FGF20
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 50.8 | 44.1 | 5.1
| HCB | 31.8 | 43.2 | 25.0
| JPT | 17.5 | 55.0 | 27.5
| YRI | 22.2 | 50.8 | 27.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 31.8 | 43.2 | 25.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}Associated with [[Parkinson's disease]] based on a conditional logistic regression analysis.{{PMID|18205889}}

{{ neighbor
| rsid = 1721100
| distance = 366
}}

{{PMID|18252210|OA=1
}} Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}